Anti-DNAJC19 monoclonal antibody

Pre-made anti-DNAJC19 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DNAJC19/DNAJC19 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0710-Ab-1/ GM-Tg-hg-IP0710-Ab-2Anti-Human DNAJC19 monoclonal antibodyHuman
GM-Tg-rg-IP0710-Ab-1/ GM-Tg-rg-IP0710-Ab-2Anti-Rat DNAJC19 monoclonal antibodyRat
GM-Tg-mg-IP0710-Ab-1/ GM-Tg-mg-IP0710-Ab-2Anti-Mouse DNAJC19 monoclonal antibodyMouse
GM-Tg-cynog-IP0710-Ab-1/ GM-Tg-cynog-IP0710-Ab-2Anti-Cynomolgus/ Rhesus macaque DNAJC19 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0710-Ab-1/ GM-Tg-felg-IP0710-Ab-2Anti-Feline DNAJC19 monoclonal antibodyFeline
GM-Tg-cang-IP0710-Ab-1/ GM-Tg-cang-IP0710-Ab-2Anti-Canine DNAJC19 monoclonal antibodyCanine
GM-Tg-bovg-IP0710-Ab-1/ GM-Tg-bovg-IP0710-Ab-2Anti-Bovine DNAJC19 monoclonal antibodyBovine
GM-Tg-equg-IP0710-Ab-1/ GM-Tg-equg-IP0710-Ab-2Anti-Equine DNAJC19 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0710-Ab-1/ GM-Tg-hg-IP0710-Ab-2; GM-Tg-rg-IP0710-Ab-1/ GM-Tg-rg-IP0710-Ab-2;
GM-Tg-mg-IP0710-Ab-1/ GM-Tg-mg-IP0710-Ab-2; GM-Tg-cynog-IP0710-Ab-1/ GM-Tg-cynog-IP0710-Ab-2;
GM-Tg-felg-IP0710-Ab-1/ GM-Tg-felg-IP0710-Ab-2; GM-Tg-cang-IP0710-Ab-1/ GM-Tg-cang-IP0710-Ab-2;
GM-Tg-bovg-IP0710-Ab-1/ GM-Tg-bovg-IP0710-Ab-2; GM-Tg-equg-IP0710-Ab-1/ GM-Tg-equg-IP0710-Ab-2
Products NameAnti-DNAJC19 monoclonal antibody
Formatmab
Target NameDNAJC19
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DNAJC19 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0710-Ag-1Recombinant multi-species TIM14/ DNAJC19/ PAM18 protein


    Target information

    Target IDGM-IP0710
    Target NameDNAJC19
    Gene ID131118,67713,502525,710082,100856039,101094003,513918,100058535
    Gene Symbol and Synonyms1810055D05Rik,DNAJC19,PAM18,RGD1560220,TIM14,TIMM14
    Uniprot AccessionQ96DA6,Q3ZBN8
    Uniprot Entry NameTIM14_HUMAN,TIM14_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000205981
    Target ClassificationN/A

    The target: DNAJC19, gene name: DNAJC19, also named as PAM18, TIM14, TIMM14. The protein encoded by this gene is thought to be part of a complex involved in the ATP-dependent transport of transit peptide-containing proteins from the inner cell membrane to the mitochondrial matrix. Defects in this gene are a cause of 3-methylglutaconic aciduria type 5 (MGA5), also known as dilated cardiomyopathy with ataxia (DCMA). Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1, 2, 6, 10, 14 and 19. [provided by RefSeq, Jan 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.